External validations of the ABCD2 score in prediction of stroke risk after transient ischemic attack. A Tunisian hospital-based cohort study.

ABCD2 score Transient ischemic attack risk assessment

Journal

The International journal of neuroscience
ISSN: 1563-5279
Titre abrégé: Int J Neurosci
Pays: England
ID NLM: 0270707

Informations de publication

Date de publication:
Dec 2023
Historique:
pubmed: 17 10 2020
medline: 17 10 2020
entrez: 16 10 2020
Statut: ppublish

Résumé

Identification of patients with high risk of stroke after transient ischemic attack (TIA) could be helpful to optimize stroke prevention. We aimed to externally validate the ABCD2 score for the prediction of stroke after TIA in a Tunisian population. We conducted a retrospective observational study of consecutive patients admitted for TIA in four university hospitals in Tunisia. Patients were screened for onset of stroke. Sensitivity, specificity, positive and negative predictive values with areas under the receiver operating characteristic (ROC) curves were calculated for risk of stroke at 2, 7, 30 and 90 days after the index event. Of 415 patients screened in this study, the total cumulative subsequent stroke rates after TIA at 2, 7, 30 and 90 days were respectively, 4.8%, 10.6%, 13.5% and 20.2%. Using a cut-off value of 4, the ABCD2 showed an overall good sensitivity (95%, 97.7%, 96.4% and 97.6% respectively at 2, 7, 30 and 90 days). Areas under ROC cure of the ABCD2 score in patients with TIA for stroke onset at 2, 7, 30 and 90 days were respectively 0.67 (95% CI, 0.55-0.79), 0.79 (95% CI, 0.71-0.85), 0.79 (95% CI, 0.72-0.85), and 0.76 (95% CI, 0.70-0.81). Our findings suggest that the ABCD2 score could be used in our population to discriminate patient with TIA at low and high risk of developing recurrent stroke.

Sections du résumé

BACKGROUND AND PURPOSE UNASSIGNED
Identification of patients with high risk of stroke after transient ischemic attack (TIA) could be helpful to optimize stroke prevention. We aimed to externally validate the ABCD2 score for the prediction of stroke after TIA in a Tunisian population.
METHODS UNASSIGNED
We conducted a retrospective observational study of consecutive patients admitted for TIA in four university hospitals in Tunisia. Patients were screened for onset of stroke. Sensitivity, specificity, positive and negative predictive values with areas under the receiver operating characteristic (ROC) curves were calculated for risk of stroke at 2, 7, 30 and 90 days after the index event.
RESULTS UNASSIGNED
Of 415 patients screened in this study, the total cumulative subsequent stroke rates after TIA at 2, 7, 30 and 90 days were respectively, 4.8%, 10.6%, 13.5% and 20.2%. Using a cut-off value of 4, the ABCD2 showed an overall good sensitivity (95%, 97.7%, 96.4% and 97.6% respectively at 2, 7, 30 and 90 days). Areas under ROC cure of the ABCD2 score in patients with TIA for stroke onset at 2, 7, 30 and 90 days were respectively 0.67 (95% CI, 0.55-0.79), 0.79 (95% CI, 0.71-0.85), 0.79 (95% CI, 0.72-0.85), and 0.76 (95% CI, 0.70-0.81).
CONCLUSION UNASSIGNED
Our findings suggest that the ABCD2 score could be used in our population to discriminate patient with TIA at low and high risk of developing recurrent stroke.

Identifiants

pubmed: 33059508
doi: 10.1080/00207454.2020.1835897
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1218-1223

Auteurs

Daoussi Nizar (D)

Department of Neurology, University Hospital of Monastir, Monastir, Tunisia.

MSolli M Amine (MM)

Research Laboratory LR12SP18, University of Monastir, Monastir, Tunisia.
Emergency Department, University Hospital of Monastir, Monastir, Tunisia.

Mouna Aissi (M)

Department of Neurology, University Hospital of Monastir, Monastir, Tunisia.

Rafik Machraoui (R)

Department of Endocrinology and Internal Medicine, Tahar Sfar Hospital of Mahdia, Mahdia, Tunisia.

Sekma Adel (S)

Research Laboratory LR12SP18, University of Monastir, Monastir, Tunisia.
Emergency Department, University Hospital of Monastir, Monastir, Tunisia.

Bel Haj Ali Khaoula (BHA)

Research Laboratory LR12SP18, University of Monastir, Monastir, Tunisia.
Emergency Department, University Hospital of Monastir, Monastir, Tunisia.

Semir Blel (S)

Neurology Department, Mongi Ben Hmida National Institute of Neurology, Tunis, Tunisia.

Samia Younes (S)

Department of Endocrinology and Internal Medicine, Tahar Sfar Hospital of Mahdia, Mahdia, Tunisia.

Riadh Boukef (R)

Emergency Department, Sahloul University Hospital, Sousse, Tunisia.

Fayçal Henteti (F)

Neurology Department, Mongi Ben Hmida National Institute of Neurology, Tunis, Tunisia.

Semir Nouira (S)

Research Laboratory LR12SP18, University of Monastir, Monastir, Tunisia.
Emergency Department, University Hospital of Monastir, Monastir, Tunisia.

Boubaker Hamdi (B)

Research Laboratory LR12SP18, University of Monastir, Monastir, Tunisia.
Emergency Department, University Hospital of Monastir, Monastir, Tunisia.

Mahbouba Frih (M)

Department of Neurology, University Hospital of Monastir, Monastir, Tunisia.

Classifications MeSH